Tekla Capital Management LLC Cyma Bay Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.47 - $4.42 $305,713 - $389,410	-88,102 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$6.05 - $13.66 $533,017 - $1.2 Million	88,102 New	88,102 $631,000
Q4 2018 Feb 13, 2019	SELL	$6.54 - $11.74 $1.11 Million - $2 Million	-169,962 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$9.0 - $15.16 $360,000 - $606,400	-40,000 Reduced 19.05%	169,962 $2.21 Million
Q3 2017 Nov 13, 2017	BUY	$5.95 - $8.26 $1.25 Million - $1.73 Million	209,962	209,962 $1.69 Million

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.